Frederick Daenen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Frederick Daenen has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Aline De Vleminck
Affiliations End-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) & Ghent University, Brussels, Belgium, Department of Family Medicine and Chronic Care, Vrije Universiteit Brussel (VUB), Brussels, Belgium
2 shared publications Kim Beernaert
Affiliations End-of-life Care Research Group, Vrije Universiteit Brussel (VUB) & Ghent University, Brussels, Belgium, Department of Public Health and Primary Care, Ghent University, Gent, Belgium
2 shared publicationsKoen Pardon
Affiliations End-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) & Ghent University, Brussels, Belgium, Department of Family Medicine and Chronic Care, Vrije Universiteit Brussel (VUB), Brussels, Belgium
2 shared publicationsAnna Skold
Southeast Permanente Medical Group, Atlanta, GA, USA
1 shared publicationAnne van Driessche
Affiliations End-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) & Ghent University, Brussels, Belgium, Department of Family Medicine and Chronic Care, Vrije Universiteit Brussel (VUB), Brussels, Belgium
1 shared publicationAnne-Lore Scherrens
Affiliations End-of-life Care Research Group, Vrije Universiteit Brussel (VUB) & Ghent University, Brussels, Belgium, Department of Public Health and Primary Care, Ghent University, Gent, Belgium
1 shared publication
Latest Publications
- Open Access
- 5 May 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (5) , e0347349
Integration of palliative care into phase I oncology trials: A qualitative interview study with patients, informal caregivers, and healthcare providers
Background: Patients with advanced cancer participating in phase I clinical trials often face limited survival while experiencing significant symptom burden. Despite evidence supporting early palliative care integration alongside active cancer treatment to improve quality of life, the role of palliative care in phase I trials remains unclear. Objective: To explore perspectives of patients, informal caregivers, and healthcare providers on quality of life and palliative care in phase I oncology trials, including perceived benefits, barriers, and integration strategies. Methods: We conducted a multi-perspective qualitative interview study across three Belgian university hospitals from September 2022 to July 2024, using convenience and snowball sampling. The semi-structured interviews were analyzed using qualitative content analysis. Ethical approval was gained from the relevant institutions. Results: Participants included sixteen patients, five informal caregivers, twelve phase I staff, six oncologists, five palliative care specialists, and four general practitioners. Patients generally reported positive experiences with trial participation, often viewing it as a final opportunity that provided hope and structure. However, quality of life support was inconsistently addressed and largely reactive. While patients reported feeling supported, non-trial providers and caregivers noted limited person-centered care. No systematic approach for introducing palliative care was in place. Palliative care was rarely discussed, hindered by misconceptions such as equating palliative care with terminal care, reluctance from patients and clinicians, and lack of communication between providers. Participants suggested the introduction of routine yet flexible palliative care conversations, as well as improved communication between providers, as strategies towards integration. Conclusion: Despite recognized care needs, palliative care is not systematically integrated in phase I oncological trials. Quality of life remains a secondary concern. Integrating palliative care in a structured yet flexible manner could support more holistic, patient-centered care. These findings underscore the need to normalize palliative care as a complementary component of phase I oncological trials.
- 5 May 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (5) , e0347349
Open AccessIntegration of palliative care into phase I oncology trials: A qualitative interview study with patients, informal caregivers, and healthcare providers
Background: Patients with advanced cancer participating in phase I clinical trials often face limited survival while experiencing significant symptom burden. Despite evidence supporting early palliative care integration alongside active cancer treatment to improve quality of life, the role of palliative care in phase I trials remains unclear. Objective: To explore perspectives of patients, informal caregivers, and healthcare providers on quality of life and palliative care in phase I oncology trials, including perceived benefits, barriers, and integration strategies. Methods: We conducted a multi-perspective qualitative interview study across three Belgian university hospitals from September 2022 to July 2024, using convenience and snowball sampling. The semi-structured interviews were analyzed using qualitative content analysis. Ethical approval was gained from the relevant institutions. Results: Participants included sixteen patients, five informal caregivers, twelve phase I staff, six oncologists, five palliative care specialists, and four general practitioners. Patients generally reported positive experiences with trial participation, often viewing it as a final opportunity that provided hope and structure. However, quality of life support was inconsistently addressed and largely reactive. While patients reported feeling supported, non-trial providers and caregivers noted limited person-centered care. No systematic approach for introducing palliative care was in place. Palliative care was rarely discussed, hindered by misconceptions such as equating palliative care with terminal care, reluctance from patients and clinicians, and lack of communication between providers. Participants suggested the introduction of routine yet flexible palliative care conversations, as well as improved communication between providers, as strategies towards integration. Conclusion: Despite recognized care needs, palliative care is not systematically integrated in phase I oncological trials. Quality of life remains a secondary concern. Integrating palliative care in a structured yet flexible manner could support more holistic, patient-centered care. These findings underscore the need to normalize palliative care as a complementary component of phase I oncological trials.
- 28 February 2025
- Published by Wiley in European journal of pain
- Vol. 29 (4) , e70005
Assessing Child Pain‐Related Injustice Appraisals: A Discriminant Content Analysis Study
Background: Child pain‐related injustice appraisals, associated with adverse pain‐related functioning, are commonly assessed using the Injustice Experience Questionnaire (IEQ). However, the IEQ was initially developed for adults. Recent qualitative phenomenological work highlighted pain‐related injustice themes among children that are seemingly not captured by the IEQ. Furthermore, research in adults and children has shown strong associations between the IEQ and both pain catastrophising and disability. These issues raise concerns regarding the content validity and discriminant content validity of the IEQ for paediatric populations. This study assessed the content validity and discriminant content validity of the IEQ items and a set of novel items generated through previous qualitative work. Methods: Content and discriminant content validity of the items was assessed by 96 adult judges rating items as measuring child injustice appraisals, as well as measuring competing constructs: pain catastrophising, disability and negative affect. Wilcoxon signed‐rank tests were applied to assess content and discriminant content validity. Results: Four of 12 IEQ items displayed content validity as well as discriminant content validity against pain catastrophising and disability. Eight of 13 newly generated items displayed content validity as well as discriminant content validity against pain catastrophising and disability. Only two of all 25 items displayed discriminant content validity against negative affect. Conclusions: This study revealed the IEQ to lack discriminant content validity for use in a paediatric context. An item pool was created to assess child pain‐related injustice appraisals, displaying both content validity and discriminant content validity against the competing constructs of pain catastrophising and disability. Significance Statement: The current study both reveals issues in applying the IEQ to assess child pain‐related injustice appraisals and advances research on child pain‐related injustice appraisals by providing an item pool displaying both content validity and discriminant content validity against the competing constructs of child pain catastrophising and child disability.
- 28 February 2025
- Published by Wiley in European journal of pain
- Vol. 29 (4) , e70005
Assessing Child Pain‐Related Injustice Appraisals: A Discriminant Content Analysis Study
Background: Child pain‐related injustice appraisals, associated with adverse pain‐related functioning, are commonly assessed using the Injustice Experience Questionnaire (IEQ). However, the IEQ was initially developed for adults. Recent qualitative phenomenological work highlighted pain‐related injustice themes among children that are seemingly not captured by the IEQ. Furthermore, research in adults and children has shown strong associations between the IEQ and both pain catastrophising and disability. These issues raise concerns regarding the content validity and discriminant content validity of the IEQ for paediatric populations. This study assessed the content validity and discriminant content validity of the IEQ items and a set of novel items generated through previous qualitative work. Methods: Content and discriminant content validity of the items was assessed by 96 adult judges rating items as measuring child injustice appraisals, as well as measuring competing constructs: pain catastrophising, disability and negative affect. Wilcoxon signed‐rank tests were applied to assess content and discriminant content validity. Results: Four of 12 IEQ items displayed content validity as well as discriminant content validity against pain catastrophising and disability. Eight of 13 newly generated items displayed content validity as well as discriminant content validity against pain catastrophising and disability. Only two of all 25 items displayed discriminant content validity against negative affect. Conclusions: This study revealed the IEQ to lack discriminant content validity for use in a paediatric context. An item pool was created to assess child pain‐related injustice appraisals, displaying both content validity and discriminant content validity against the competing constructs of pain catastrophising and disability. Significance Statement: The current study both reveals issues in applying the IEQ to assess child pain‐related injustice appraisals and advances research on child pain‐related injustice appraisals by providing an item pool displaying both content validity and discriminant content validity against the competing constructs of child pain catastrophising and child disability.
- Open Access
- 13 December 2024
- Published by SAGE Publications in Palliative Medicine
- Vol. 39 (2) , 266-276
Associations between physicians’ personal preferences for end-of-life decisions and their own clinical practice: PROPEL survey study in Europe, North America, and Australia
Background: Physicians have significant influence on end-of-life decisions. Therefore, it is important to understand the connection between physicians’ personal end-of-life care preferences and clinical practice, and whether there is congruence between what they prefer for themselves and for patients. Aim: Study to what extent physicians believe their personal end-of-life preferences impact their clinical practice and to what extent physicians’ personal treatment option preferences differ from what they prefer for their patients. Design: A cross-sectional survey was conducted from May 2022 to February 2023. Setting/participants: Eight jurisdictions: Belgium, Italy, Canada, USA (Oregon, Wisconsin, and Georgia), and Australia (Victoria and Queensland). Three physician types were included: general practitioners, palliative care physicians, and other medical specialists. Results: We analyzed 1157 survey responses. Sixty-two percent of physicians acknowledge considering their own preferences when caring for patients at the end of life and 29.7% believe their personal preferences impact the recommendations they make. Palliative care physicians are less likely to consider their own preferences when caring for and making recommendations to patients. Congruence was found between what physicians prefer for patients and themselves with cardiopulmonary resuscitation considered “not a good option for both” by 99.1% of physicians. Incongruence was found with physicians considering some options “not good for the patient, but good for themselves”—palliative sedation (8.3%), physician-assisted suicide (7.0%), and euthanasia (11.6%). Conclusion: Physicians consider their own preferences when providing care and their preferences impact the recommendations they make to patients. Incongruence exists between what physicians prefer for themselves and what they prefer for patients.
- 13 December 2024
- Published by SAGE Publications in Palliative Medicine
- Vol. 39 (2) , 266-276
Open AccessAssociations between physicians’ personal preferences for end-of-life decisions and their own clinical practice: PROPEL survey study in Europe, North America, and Australia
Background: Physicians have significant influence on end-of-life decisions. Therefore, it is important to understand the connection between physicians’ personal end-of-life care preferences and clinical practice, and whether there is congruence between what they prefer for themselves and for patients. Aim: Study to what extent physicians believe their personal end-of-life preferences impact their clinical practice and to what extent physicians’ personal treatment option preferences differ from what they prefer for their patients. Design: A cross-sectional survey was conducted from May 2022 to February 2023. Setting/participants: Eight jurisdictions: Belgium, Italy, Canada, USA (Oregon, Wisconsin, and Georgia), and Australia (Victoria and Queensland). Three physician types were included: general practitioners, palliative care physicians, and other medical specialists. Results: We analyzed 1157 survey responses. Sixty-two percent of physicians acknowledge considering their own preferences when caring for patients at the end of life and 29.7% believe their personal preferences impact the recommendations they make. Palliative care physicians are less likely to consider their own preferences when caring for and making recommendations to patients. Congruence was found between what physicians prefer for patients and themselves with cardiopulmonary resuscitation considered “not a good option for both” by 99.1% of physicians. Incongruence was found with physicians considering some options “not good for the patient, but good for themselves”—palliative sedation (8.3%), physician-assisted suicide (7.0%), and euthanasia (11.6%). Conclusion: Physicians consider their own preferences when providing care and their preferences impact the recommendations they make to patients. Incongruence exists between what physicians prefer for themselves and what they prefer for patients.
- 26 June 2024
- Published by BMJ in BMJ Supportive & Palliative Care
- Vol. 14 (e3) , e2510-e2514
General practitioner advance care planning knowledge and attitudes: ACP-GP cluster-randomised controlled trial
Objectives Advance care planning (ACP) supports adults understanding and sharing their values, goals, and preferences regarding future medical care. General practitioners (GPs) are key figures in conducting ACP conversations with patients. GPs’ ACP knowledge and attitudes have been identified as potential barriers. This study evaluates the effects of ACP-GP, a complex ACP intervention, on GPs’ knowledge and attitudes. Methods A phase-III cluster-randomised controlled trial. 35 Belgian GPs participated. The intervention included a training for GPs, ACP conversations, a patient workbook, and a documentation template. GPs’ knowledge and attitudes were assessed using an adaptation of the Next Steps questionnaire, at baseline, three, and six months postintervention. Generalised estimating equations were applied to analyse the data. Results Analyses showed no intervention effect on GPs’ knowledge (W(2)=4.18, p=.123) and attitudes (all W(2).146) compared with the control group. Conclusions The ACP-GP intervention did not improve GPs’ knowledge and attitudes. Failure to detect an effect may stem from a ceiling effect, with GPs scoring high on baseline outcomes across groups. Questionnaires may require fine-tuning to accurately map their suggested role as potential barriers. Trial registration number Prospectively registered at ISRCTN (ISRCTN12995230) on 19 June 2020.
- 26 June 2024
- Published by BMJ in BMJ Supportive & Palliative Care
- Vol. 14 (e3) , e2510-e2514
General practitioner advance care planning knowledge and attitudes: ACP-GP cluster-randomised controlled trial
Objectives Advance care planning (ACP) supports adults understanding and sharing their values, goals, and preferences regarding future medical care. General practitioners (GPs) are key figures in conducting ACP conversations with patients. GPs’ ACP knowledge and attitudes have been identified as potential barriers. This study evaluates the effects of ACP-GP, a complex ACP intervention, on GPs’ knowledge and attitudes. Methods A phase-III cluster-randomised controlled trial. 35 Belgian GPs participated. The intervention included a training for GPs, ACP conversations, a patient workbook, and a documentation template. GPs’ knowledge and attitudes were assessed using an adaptation of the Next Steps questionnaire, at baseline, three, and six months postintervention. Generalised estimating equations were applied to analyse the data. Results Analyses showed no intervention effect on GPs’ knowledge (W(2)=4.18, p=.123) and attitudes (all W(2).146) compared with the control group. Conclusions The ACP-GP intervention did not improve GPs’ knowledge and attitudes. Failure to detect an effect may stem from a ceiling effect, with GPs scoring high on baseline outcomes across groups. Questionnaires may require fine-tuning to accurately map their suggested role as potential barriers. Trial registration number Prospectively registered at ISRCTN (ISRCTN12995230) on 19 June 2020.